|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Differential alterations of type Ⅲ and Ⅳ collagen protein expression in experimental venous bypass grafting显示文摘 | Annex BH Denning SM Fulton GC | 1996 | J Am Coll Cardiol1996，27，2： | 1 |
| 2 | The VIVA trial:Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis显示文摘 | Henry TD Annex BH McKendall GR | | 0，，： | 1 |
| 3 | The viva trival: vascular endothelial growth factor in ischemia for vascular angiogenesis显示文摘 | HENRY TD ANNEX BH MEKENDALL GR | 2003 | Circulation2003，107，10： | 1 |
| 4 | Double blind, placebo controlled trial of recombinant human vascular endothelial growth factor The VIVA trial 显示文摘 | Henry TD Annex BH Azrin MA | 1999 | J Am Coll Cardiol1999，33，： | 1 |
| 5 | Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial显示文摘 | Simons M Annex BH Laham RJ | 2002 | Circulation2002，105，7： | 1 |
| 6 | Growth factors for therapeutic angiogenesis in peripheral arterial disease显示文摘 | Jones WS Annex BH | 2007 | Curr Opin Cardiol2007，22，5： | 1 |
| 7 | The VIVA trial: vascular endothelial growth factor in ischemia for vascular angiogenesis显示文摘 | Henry TD Annex BH McKendall GR | 2003 | Circulation2003，，10： | 1 |
| 8 | Growth factors for therapeutic angiogenesis in hypercholesterolemic erectile dysfunction显示文摘过去的十年看见了可勃起的机能障碍(编辑) 的阴茎勃起,和 pathophysi 科学的生理学的新信息的爆炸。如果阴茎脉管系统被包含,血胆脂醇过多是能在编辑在脉管系统床和罐头结果上导致退化的一个长期的条件。血管生成是从先存在的新血管的生长脉管系统。治疗学的血管生成寻求利用脉管的生长的机制对待不适当的组织灌注的混乱,例如在那里的冠的动脉疾病和编辑是在过去的十年的治疗学的血管生成的地里的巨大的变化,并且为未来有许多诺言。有 cytokine 生长因素交货的起始的现出症状之前的潜的工作为处理导致了很多热情是化学家心或外部脉管的疾病,不过,临床的研究没获得类似的成功。与涉及血管生成的复杂机制的增加的理解,多重不同 angiogenic 小径也是哪个目标的新奇治疗正在被开发并且测试。因为它的外部地点和可接近性,阴茎是为基因治疗的一个方便织物目标,内皮的普遍存在衬里血流的空格,和底层,特别处于松驰的状态。治疗学的血管生成是继续演变的一块令人激动的地。这评论将在动物研究为 hypercholesterolemic 编辑,为编辑治疗的各种各样的生长因素的使用,他们交货的线路,和结果集中于生长因素的发展。 | Donghua Xie Brian H. Annex Craig F. Donatucci | 2008 | Asian Journal of Andrology2008，10，1： | 1 |
| 9 | Angiogenic therapy for coronary artery and peripheral arterial disease显示文摘 | Hughes GC Annex BH | 2005 | Expert Rev Cardiovasc Ther2005，3，3： | 1 |
| 10 | Plasticity of myocytes and capilliaries a pos-sible corrdinating role for VEGF显示文摘 | Williams RS Annex BH | 2004 | Circ Res2004，95，1： | 1 |
| 11 | Growth factors for therapeutic angio- genesis in peripheral arterial disease 显示文摘 | Jones WS Annex BH | 2007 | Curr Opin Cardiol2007，22，5： | 1 |
| 12 | Final results of the VIVA trial of rh VEGF human therapeutic angiogenesis显示文摘 | Henry T Annex B Azrin M | 1999 | Circulation1999，100，： | 1 |
| 13 | The VIVA trial:Vascular endothelial growth factor in ischemia for vascular angiogenesis显示文摘 | Henry TD Annex BH mcKendall GR | 2003 | Circulation2003，107，： | 1 |
| 14 | The VIVA trail:VEGF in ischemia for vascular angiogenesis显示文摘 | HENRY T D ANNEX B H MCKENDALL G R | 2003 | Circulation2003，107，： | 1 |
| 15 | Induction and maintenance of increased VEGF protein by chronic motor nerve stimulation in skeletal muscle显示文摘 | Torgan CE Lin P | 1998 | Am J Physiol1998，274，： | 1 |
| 16 | Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized,controlled clinical trial显示文摘 | Simons M Annex BH Laham R J | 2002 | Crculation2002，105，7： | 1 |
| 17 | The VIVA trial vascular endothelial growth factor in ischemia for vascular angiogenesis 显示文摘 | Henry TD Annex BH McKendall GR | 2003 | Circulation2003，107，： | 1 |
| 18 | Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2 double-blind, randomized ,controlled clinical trial 显示文摘 | Simons M Annex BH Laham R J | 2002 | Circulation2002，105，： | 1 |
| 19 | IMPAIRED ANGIOGENESIS FOLLOWING HIND-LIMB ISCHEMIA IN DIABETES MELLITUS MICE显示文摘Objective To investigate vascular endothelial growth factor(VEGF) and its signaling pathway spontaneous response in type 2 diabetes mellitus(T2DM) mice to surgery-induced hind-limb ischemia.Methods Sixty mice were randomly divided into two groups,one was fed with normal chow as control,and another was fed with high fat diet to induce T2DM.Fourteen weeks later,mice were surgically induced to hind-limb ischemia.Blood flow restoration was monitored with laser Doppler perfusion imaging.Tibialis anterior muscle was collected after 3 days of hind-limb ischemia.VEGF mRNA and protein expressions were analyzed using real-time PCR and ELISA;expressions of VEGF downstream signal molecules and receptors were analyzed using Western blotting and RT-PCR,respectively.Results Perfusion recovery 10,20,30 days after ischemia was significantly attenuated in T2DM compared with control group(P<0.05).T2DM impaired VEGF signaling pathway although VEGF levels increased in T2DM group.After ischemia,T2DM group had a comparable increase in VEGF expression compared with control group,but still had an impaired VEGF signaling pathway.Conclusion VEGF signaling pathway is abnormal in T2DM mice,although VEGF had a response to the ischemic stimulation. | Yong-jun Li Heng Guan Surovi Hazarika Chang-wei Liu Brain H Annex | 2007 | Chinese Medical Sciences Journal2007，22，4： | 1 |
| 20 | The viva trival:vascular endothelial growth factor in ischemia for vascular angiogenesis 显示文摘 | Annex BH McKendall GR | 2003 | Circulation2003，107，10： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员